Exam guide
USMLE Step 3
The final step — clinical management independent of supervision.
About the exam
USMLE Step 3 is the culmination of the United States medical licensing examination series, assessing whether a physician possesses the clinical judgment and technical competency necessary for unsupervised, independent medical practice. Typically undertaken during the first or second year of residency (PGY-1/PGY-2), passing Step 3 is an essential legal prerequisite for obtaining a permanent, unrestricted state medical license. Furthermore, for international medical graduates, passing Step 3 is a mandatory statutory requirement to qualify for H-1B temporary worker visa sponsorship by residency training programs. The examination spans two distinct days and features interactive computer-based case simulations alongside traditional multiple-choice questions.
How ClinIQ prepares you
ClinIQ's Step 3 preparation suite is purpose-built for the reality of busy residency schedules, offering mobile-optimized question sets that focus on acute inpatient and ambulatory management, medical literature evaluation, and biostatistics. Detailed rationales clarify the nuances of diagnostic sequencing and longitudinal monitoring. Spaced-repetition flashcards preserve high-yield pharmacotherapy facts, critical toxicology protocols, and emergency drug dosages between hospital shifts, while smart performance dashboards track readiness against the official Step 3 blueprint.
Subjects covered
The ClinIQ question bank spans the full USMLE Step 3 blueprint. Practice by subject, or in mixed blocks that mirror the real exam:
USMLE Step 3 — frequently asked questions
When should I take USMLE Step 3, and does it affect my visa?
Most resident physicians sit for Step 3 during their intern year (PGY-1) or early in PGY-2, as state medical boards require passing scores for full licensure and training progression. For international medical graduates, timing is particularly vital: passing Step 3 prior to the Match or early in the application season is mandatory if seeking H-1B visa sponsorship from residency programs, which avoids the mandatory two-year home-country return requirement associated with J-1 exchange visitor visas.
What are Computer-based Case Simulations (CCS), and how are they graded?
Computer-based Case Simulations (CCS) on Day 2 of Step 3 represent approximately 25 to 30 percent of your composite score. Candidates manage 13 to 14 simulated clinical encounters in real time, entering free-text orders for physical exams, labs, diagnostic imaging, acute medications, nursing orders, and consultations while advancing the virtual simulation clock. Scoring algorithms evaluate the appropriateness, timeliness, and safety of your clinical orders, penalizing invasive or unnecessary interventions while rewarding prompt stabilization.
How do Day 1 (FIP) and Day 2 (ACM) of Step 3 differ?
Step 3 is divided across two separate testing days: Day 1, titled Foundations of Independent Practice (FIP), lasts approximately seven hours and contains 232 multiple-choice questions emphasizing basic science mechanisms, clinical diagnosis, medical literature appraisal, and advanced biostatistics. Day 2, titled Advanced Clinical Medicine (ACM), lasts approximately nine hours and consists of 180 multiple-choice questions focusing on longitudinal patient management and prognosis, followed by 13 to 14 interactive CCS cases.
How can a resident prepare for Step 3 while working full-time clinical hours?
The most sustainable preparation strategy relies on consistent, bite-sized daily study habits rather than marathon weekend cramming. Dedicate 45 to 60 minutes daily to completing 15 to 20 multiple-choice questions, utilizing clinical downtime and mobile apps. On scheduled days off, practice interactive CCS cases using simulation software to master order syntax and timing. A disciplined two-to-three-month plan is generally sufficient to achieve a solid pass well above the 200 passing threshold.
Start USMLE Step 3 prep today.
Full qbank, eBook library, flashcards, and analytics — from a complimentary trial reviewed within 24 hours.